{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "27737405", "DateCompleted": {"Year": "2017", "Month": "11", "Day": "24"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.5935/1678-9741.20160054", "S0102-76382016000300226"], "Journal": {"ISSN": "1678-9741", "JournalIssue": {"Volume": "31", "Issue": "3", "PubDate": {"Year": "2016", "Season": "May-Jun"}}, "Title": "Brazilian journal of cardiovascular surgery", "ISOAbbreviation": "Braz J Cardiovasc Surg"}, "ArticleTitle": "Methylene Blue to Treat Protamine-induced Anaphylaxis Reactions. An Experimental Study in Pigs.", "Pagination": {"StartPage": "226", "EndPage": "231", "MedlinePgn": "226-231"}, "Abstract": {"AbstractText": ["To examine if methylene blue (MB) can counteract or prevent protamine (P) cardiovascular effects.", "The protocol included five heparinized pig groups: Group Sham -without any drug; Group MB - MB 3 mg/kg infusion; Group P - protamine; Group P/MB - MB after protamine; Group MB/P - MB before protamine. Nitric oxide levels were obtained by the nitric oxide/ozone chemiluminescence method, performed using the Nitric Oxide Analizer 280i (Sievers, Boulder, CO, USA). Malondialdehyde plasma levels were estimated using the thiobarbiturate technique.", "1) Groups Sham and MB presented unchanged parameters; 2) Group P - a) Intravenous protamine infusion caused mean arterial pressure decrease and recovery trend after 25-30 minutes, b) Cardiac output decreased and remained stable until the end of protamine injection, and c) Sustained systemic vascular resistance increased until the end of protamine injection; 3) Methylene blue infusion after protamine (Group P/MB) - a) Marked mean arterial pressure decreased after protamine, but recovery after methylene blue injection, b) Cardiac output decreased after protamine infusion, recovering after methylene blue infusion, and c) Sustained systemic vascular resistance increased after protamine infusion and methylene blue injections; 4) Methylene blue infusion before protamine (Group MB/P) - a) Mean arterial pressure decrease was less severe with rapid recovery, b) After methylene blue, there was a progressive cardiac output increase up to protamine injection, when cardiac output decreased, and c) Sustained systemic vascular resistance decreased after protamine, followed by immediate Sustained systemic vascular resistance increase; 5) Plasma nitrite/nitrate and malondialdehyde values did not differ among the experimental groups.", "Reviewing these experimental results and our clinical experience, we suggest methylene blue safely prevents and treats hemodynamic protamine complications, from the endothelium function point of view."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Albuquerque", "ForeName": "Agnes Afrodite S", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Margarido", "ForeName": "Edson A", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Menardi", "ForeName": "Antonio Carlos", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Scorzoni", "ForeName": "Adilson", "Initials": "A", "Suffix": "Filho"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Celotto", "ForeName": "Andrea Carla", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Rodrigues", "ForeName": "Alfredo J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Vicente", "ForeName": "Walter Vilella A", "Initials": "WV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endothelium and Cardiovascular Function; Department of Surgery and Anatomy, Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FMRP-USP), SP, Brazil."}], "LastName": "Evora", "ForeName": "Paulo Roberto B", "Initials": "PR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Brazil", "MedlineTA": "Braz J Cardiovasc Surg", "NlmUniqueID": "101677045", "ISSNLinking": "0102-7638"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Heparin Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Protamines"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "T42P99266K", "NameOfSubstance": "Methylene Blue"}], "MeshHeadingList": [{"QualifierName": ["etiology", "prevention & control"], "DescriptorName": "Anaphylaxis"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Central Venous Pressure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Heparin Antagonists"}, {"QualifierName": ["blood"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methylene Blue"}, {"QualifierName": [], "DescriptorName": "Models, Animal"}, {"QualifierName": ["blood"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["adverse effects", "antagonists & inhibitors"], "DescriptorName": "Protamines"}, {"QualifierName": [], "DescriptorName": "Swine"}], "CoiStatement": "No conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pearson PJ, Evora PR, Ayrancioglu K, Schaff HV. Protamine releases endothelium-derived relaxing factor from systemic arteries: a possible mechanism of hypotension during heparin neutralization. Circulation. 1992;86(1):289\u2013294.", "ArticleIdList": ["1617779"]}, {"Citation": "Evora PR, Pearson PJ, Schaff HV. Protamine induces endotheliumdependent vasodilation of the pulmonary artery. Ann Thorac Surg. 1995;60(2):405\u2013410.", "ArticleIdList": ["7646104"]}, {"Citation": "Raikar GV, Hisamochi K, Raikar BL, Schaff HV. Nitric oxide inhibition attenuates systemic hypotension produced by protamine. Thorac Cardiovasc Surg. 1996;111(6):1240\u20131246.", "ArticleIdList": ["8642826"]}, {"Citation": "Cable DG, Sorajja P, Oeltjen MR, Schaff HV. Different effects of protamine on canine coronary microvessel and conductance arteries: evidence of hyperpolarizing factor release. Surgery. 1999;126(5):835\u2013841.", "ArticleIdList": ["10568182"]}, {"Citation": "Viaro F, Dalio MB, Evora PR. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice? Chest. 2002;122(3):1061\u20131066.", "ArticleIdList": ["12226053"]}, {"Citation": "Marin-Neto JA, Sykes MK, Marin JL, Orchard C, Chakrabarti MK. Effect of heparin and protamine on left ventricular performance in the dog. Cardiovasc Res. 1979;13(5):254\u2013259.", "ArticleIdList": ["476745"]}, {"Citation": "Jaques LB. A study of the toxicity of the protamine, salmine. Br J Pharmacol Chemother. 1949;4(2):135\u2013144.", "ArticleIdList": ["PMC1509871", "18149707"]}, {"Citation": "Jones MM, Hill AB, Nahrwold ML, Tait AR. Effect of protamine on plasma ionized calcium in the dog. Can Anaesth Soc. 1982;29(1):65\u201367.", "ArticleIdList": ["7055745"]}, {"Citation": "Shapira N, Schaff HV, Piehler JM, White RD, Still JC, Pluth JR. Cardiovascular effects of protamine sulfate in man. J Thorac Cardiovasc Surg. 1982;84(4):505\u2013514.", "ArticleIdList": ["7121041"]}, {"Citation": "Milne B, Rogers K, Cervenko F, Salerno T. The hemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man. Can Anaesth Soc J. 1983;30(4):347\u2013351.", "ArticleIdList": ["6871776"]}, {"Citation": "Frater RW, Oka Y, Hong Y, Tsubo T, Loubser PG, Masone R. Protamineinduced circulatory changes. J Thorac Cardiovasc Surg. 1984;87(5):687\u2013692.", "ArticleIdList": ["6609280"]}, {"Citation": "Wakefield TW, Hantler CB, Lindblad B, Whitehouse WM, Jr, Stanley JC. Protamine pretreatment attenuation of hemodynamic and hematologic effects of heparin-protamine interaction. A prospective randomized study in human beings undergoing aortic reconstructive surgery. J Vasc Surg. 1986;3(6):885\u2013889.", "ArticleIdList": ["3712636"]}, {"Citation": "Stewart WJ, McSweeney SM, Kellett MA, Faxon DP, Ryan TJ. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation. 1984;70(5):788\u2013792.", "ArticleIdList": ["6488493"]}, {"Citation": "Kirklin JK, Chenoweth DE, Naftel DC, Blackstone EH, Kirklin JW, Bitran DD, et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg. 1986;41(2):193\u2013199.", "ArticleIdList": ["3947172"]}, {"Citation": "Horrow JC. Protamine: a review of its toxicity. Anesth Analg. 1985;64(3):348\u2013361.", "ArticleIdList": ["3883848"]}, {"Citation": "Hines RL, Barash PG. Protamine: does it alter right ventricular function? Anesth Analg. 1986;65(12):1271\u20131274.", "ArticleIdList": ["3777455"]}, {"Citation": "Castresana MR, Zhang LM, Newman WH. Protamine does not affect the formation of cGMP or cAMP in pig vascular smooth muscle cells in response to vasodilators. Crit Care Med. 1995;23(5):939\u2013943.", "ArticleIdList": ["7736754"]}, {"Citation": "Panos A, Orrit X, Chevalley C, Kalangos A. Dramatic post-cardiotomy outcome, due to severe anaphylactic reaction to protamine. Eur J Cardiothorac Surg. 2003;24(2):325\u2013327.", "ArticleIdList": ["12895638"]}, {"Citation": "Lutjen DL, Arndt KL. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report. AANA J. 2012;80(3):170\u2013173.", "ArticleIdList": ["22848976"]}, {"Citation": "Del Duca D, Sheth SS, Clarke AE, Lachapelle KJ, Ergina PL. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin. Ann Thorac Surg. 2009;87(2):640\u2013642.", "ArticleIdList": ["19161806"]}, {"Citation": "Fettah ND, Dilli D, Cavusoglu H, Beken S, Ozgur S, Zenciroglu A, et al. Management of postoperative pulmonary hypertension by inhaled nitric oxide in a newborn with congenital diaphragmatic hernia. J Coll Physicians Surg Pak. 2014;24(9):690\u2013691.", "ArticleIdList": ["25233978"]}, {"Citation": "Kruzliak P, Maruyama J, Maruyama K. Role of nitric oxide in pathophysiology and treatment of pulmonary hypertension. Vitam Horm. 2014;96:407\u2013424.", "ArticleIdList": ["25189396"]}, {"Citation": "Rossaint R, Lewandowski K, Zapol WM. Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome: discovery, current understanding, and focussed targets of future applications. Intensive Care Med. 2014;40(11):1649\u20131658.", "ArticleIdList": ["25201565"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "7", "Day": "1"}, {"Year": "2016", "Month": "7", "Day": "30"}, {"Year": "2016", "Month": "10", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27737405", "PMC5062710", "10.5935/1678-9741.20160054", "S0102-76382016000300226"]}}], "PubmedBookArticle": []}